A nomogram based on LI-RADS features, clinical indicators and quantitative contrast-enhanced MRI parameters for predicting glypican-3 expression in hepatocellular carcinoma

PURPOSE: Noninvasively assessing the tumor biology and microenvironment before treatment is greatly important, and glypican-3 (GPC-3) is a new-generation immunotherapy target for hepatocellular carcinoma (HCC). This study investigated the application value of a nomogram based on LI-RADS features, qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yan, Zhang, Yue-yue, Yu, Qin, Chen, Tong, Wei, Chao-gang, Zhang, Rui, Hu, Wei, Qian, Xu-jun, Zhu, Zhi, Zhang, Xue-wu, Shen, Jun-kang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941525/
https://www.ncbi.nlm.nih.gov/pubmed/36824129
http://dx.doi.org/10.3389/fonc.2023.1123141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941525/
https://www.ncbi.nlm.nih.gov/pubmed/36824129
http://dx.doi.org/10.3389/fonc.2023.1123141

Ejemplares similares